26 August 2021
Rinicare launches new AI-driven risk prediction solution for atrial fibrillation
The STABILITY platform uses AI technology to provide advanced clinical risk prediction, and acts as an early warning system for patient deterioration … Manchester-based MedTech start-up Rinicare has launched a new application for its ground-breaking clinical risk prediction...
25 August 2021
Viscgo completes £315k investment round
Manchester-based medical device company Viscgo has a completed a £315,000 investment round. The firm, based in Manchester Science Park, has been able to complete this due to a £50,000 investment from North West early-stage investor GC Angels. This comes following...
18 August 2021
Clin-e-Cal wins share of £4m tech fund to revolutionise asthma self-management
Asthma UK and British Lung Foundation has announced the winners of their £4 million asthma tech fund which aims to kick-start a revolution in asthma self-management. The research grants, created in partnership with the National Institute for Health Research (NIHR) and the...
11 August 2021
Panthera steps up its move into oncology trials with more than 12 trials in the pipeline and a prostate trial underway
Panthera has accelerated its move into running oncology trials – as part of its partnership with Rutherford Health plc – with an open label prostate cancer trial underway and 12 more trials in the pipeline. Panthera’s partnership with Rutherford not only...
3 August 2021
Gendius to collaborate with The University of Manchester on new Human-AI research teams
Gendius has been selected to be a part of the new Human-AI research teams developed by the University of Manchester to help cure humanity's complex future health and societal problems through AI technology. Led by Professor Samuel Kaski from The University of Manchester, this...
2 August 2021
Infex Therapeutics sharpens Covid focus with new CRUK Newcastle partnership
Alderley Park, Cheshire – Infex Therapeutics is pressing ahead with a major development of its pandemic resilience strategy by today announcing an agreement with CRUK Newcastle Drug Discovery Unit. This will in-licence a novel therapy designed to treat SARS-CoV-2 along...
26 July 2021
Cytox strengthens team to support commercialisation of genoSCORE test to predict risk of cognitive decline due to Alzheimer’s disease
New appointments in Commercial Operations, Medical Affairs, and Bioinformatics & Genetics … 26 July 2021: Oxford & Manchester, UK. Cytox Ltd, which provides non-invasive, risk assessment and patient stratification tools for Alzheimer's disease and dementia, has...
14 July 2021
Women can buy Maxwellia’s Lovima® contraceptive pill from pharmacies for first time in UK history
WOMEN can now buy a contraceptive pill over the counter without a prescription following a consultation with a pharmacist after the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) today granted a licence to Maxwellia’s Lovima®. … This...
7 July 2021
QV Bioelectronics raises £735k for development of implanted electric field therapy device for brain cancer treatment
6th July 2021, Cheshire, UK. QV Bioelectronics (“QV”) – a medical device start-up pioneering a first of its kind electric field therapy implant for the treatment of the most common and aggressive type of brain tumours, announces it has closed a £735,000...
5 July 2021
Gendius - new partnership will help diabetics to manage their conditions
Experts at the University of Nottingham have teamed up with digital health company Gendius Limited to help promote better care for people with diabetes … The University’s Digital Research Service will work with Gendius Limited to use diabetes data to develop and embed...